GBCS — Selectis Health Cashflow Statement
0.000.00%
Last trade - 00:00- $6.44m
- $42.87m
- $36.78m
Annual cashflow statement for Selectis Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.868 | 2.96 | -2.24 | -2.4 | -3.97 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.682 | -1.32 | -0.071 | 1.64 | 3.08 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.433 | -0.487 | 0.309 | -1.34 | -0.24 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 0.869 | 2.73 | -0.271 | -0.305 | 0.537 |
| Capital Expenditures | -2.4 | -2.11 | -0.52 | -0.222 | -0.03 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.005 | 0.533 | 0 | — | — |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.41 | -1.57 | -0.52 | -0.222 | -0.03 |
| Financing Cash Flow Items | -0.009 | -0.057 | 0.654 | 0 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.22 | 1.82 | 1.61 | -1.85 | -0.619 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.315 | 2.99 | 0.815 | -2.38 | -0.112 |